NCT05581641 Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria Status COMPLETED Phase PHASE1
NCT05535465 Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities Status UNKNOWN Phase NA
NCT05471544 Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05441410 Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05426434 Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05400746 A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK Status TERMINATED Phase EARLY_PHASE1
NCT05391230 Permethrin-treated Baby-wraps for the Prevention of Malaria in Children Status COMPLETED Phase NA
NCT05385510 Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV Status COMPLETED Phase PHASE1
NCT05354258 Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children Status UNKNOWN Phase NA
NCT05343312 In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique Status COMPLETED Phase PHASE4
NCT05340153 Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon Status UNKNOWN Phase PHASE4
NCT05330273 Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz Status COMPLETED Phase PHASE1
NCT05323721 Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05317117 Evaluating the Clinical Performance and Usability of Novel Malaria RDTs in Brazil Status UNKNOWN Phase NA